(Q33746862)

29 July 2017

1 reference

title

Anti-DNA autoantibodies and systemic lupus erythematosus (English)

1 reference

systemic lupus erythematosus

29 July 2017

1 reference

0 references

author name string

Blatt NB

series ordinal

1 reference

29 July 2017

Glick GD

series ordinal

1 reference

29 July 2017

publication date

1 August 1999

1 reference

Pharmacology & Therapeutics

29 July 2017

published in

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

page(s)

125-139

1 reference

Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Platelet activating factor receptor blockade ameliorates murine systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Effect of treatment on the evolution of renal abnormalities in lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Three-dimensional structure of the Stat3beta homodimer bound to DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

1 reference

7 January 2021

Prevention of glomerulosclerosis by early cyclosporine treatment of experimental lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Anti-DNA autoantibodies: the other DNA-binding proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

The effect of cyclosporin A on early and late stages of experimental lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Prevention of Murine Lupus Nephritis by Carrier-Dependent Induction of Immunologic Tolerance to Denatured DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Cross-reactive binding patterns of monoclonal antibodies to DNA are often caused by DNA/anti-DNA immune complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Long-term treatment of systemic lupus erythematosus with cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

A DNA-reacting factor in serum of a patient with lupus erythematosus diffusus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Different mechanisms by which anti-DNA MoAbs bind to human endothelial cells and glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Protein chemistry-nuclear magnetic resonance approach to mapping functional domains in single-stranded DNA binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Lupus autoantibodies interact directly with distinct glomerular and vascular cell surface antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

The in vivo and in vitro glomerular deposition of isolated anti-double-stranded-DNA antibodies in NZB/W mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Antibody-antigen complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Molecular determinants of immunogenicity: the immunon model of immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Specific cellular stimulation in the primary immune response: experimental test of a quantized model

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Genetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB x NZW)F1 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Human IgG anti-DNA antibodies deposit in kidneys and induce proteinuria in SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Structure-function correlates of autoantibodies to nucleic acids. Lessons from immunochemical, genetic and structural studies

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Effect of a Novel Immunosuppressant, FK506, on Spontaneous Lupus Nephritis in MRL/MpJ-lpr/lpr Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Prognosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. The major glycosaminoglycan in glomerular basement membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Evidence for the Superiority of Immunosuppressive Drugs and Prednisone over Prednisone Alone in Lupus Nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Treatment of murine lupus with CTLA4Ig

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Electrostatic effects in homeodomain-DNA interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Clinical efficacy of cyclosporin a neoral in the treatment of paediatric lupus nephritis with heavy proteinuria.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Peptide inhibition of glomerular deposition of an anti-DNA antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Structure of NF-kappa B p50 homodimer bound to a kappa B site

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Chronic therapy with recombinant tumor necrosis factor-alpha in autoimmune NZB/NZW F1 mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

An autoantibody to single-stranded DNA: Comparison of the three-dimensional structures of the unliganded fab and a deoxynucleotide-fab complex

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Spontaneous auto-immune disease in NZB/BL mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Renal Disease associated with Positive Lupus Erythematosus Tests in a Crossbred Strain of Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Renal lesions in the "auto-immune" mouse strains NZB and F1 NZBxNZW

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Requirement of H-2 heterozygosity for autoimmunity in (NZB X NZW)F1 hybrid mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

IgG3 cryoglobulins in autoimmune MRL-lpr/lpr mice: immunopathogenesis, therapeutic approaches and relevance to similar human diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Immunospecific reduction of antioligonucleotide antibody-forming cells with a tetrakis-oligonucleotide conjugate (LJP 394), a therapeutic candidate for the treatment of lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Idiotypic characteristics of immunoglobulins associated with systemic lupus erythematosus. Studies of antibodies deposited in glomeruli of humans

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Mutational analysis of an autoantibody: differential binding and pathogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Immunological studies concerning the nephritis of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Equilibrium binding studies of recombinant anti-single-stranded DNA Fab. Role of heavy chain complementarity-determining regions

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

The contribution of NZW genes to lupus-like disease in (NZB x NZW)F1 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Molecular basis for the binding promiscuity of an anti-p24 (HIV-1) monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Pathogenesis of the glomerulonephritis of NZB/W mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Monoclonal antibodies showing sequence specificity in their interaction with single-stranded DNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Specificity of autoimmune monoclonal Fab fragments binding to single-stranded deoxyribonucleic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Monoclonal antibodies specific for poly(dG) X poly(dC) and poly(dG) X poly(dm5C).

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Induction of "wire-loop" lesions by murine monoclonal IgG3 cryoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Escherichia coli single-stranded DNA-binding protein: multiple DNA-binding modes and cooperativities

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Cyclosporin A in the treatment of systemic lupus erythematosus: results of an open clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Physicochemical and functional relationships of immune complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Selection of immunoglobulin variable regions in autoimmunity to DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Antiproteinuric effect of a thromboxane receptor antagonist, S-1452, on rat diabetic nephropathy and murine lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Effect of long-term anti-CD4 or anti-CD8 treatment on the development of lpr CD4- CD8- double negative T cells and of the autoimmune syndrome in MRL-lpr/lpr mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Structure, function and properties of antibody binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Structure of the NF-kappa B p50 homodimer bound to DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Antibody-nucleic acid complexes. Oligo(dG)n and -(dT)n specificities associated with anti-DNA antibodies from autoimmune MRL mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Antibody-nucleic acid complexes. Conformational and base specificities associated with spontaneously occurring poly- and monoclonal anti-DNA antibodies from autoimmune mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

A y chromosome associated factor in strain bxsb producing accelerated autoimmunity and lymphoproliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Effect of a specific endothelin A receptor antagonist on murine lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Correlations of autoimmunity with H-2 and T cell receptor beta chain genotypes in (NZB X NZW) F2 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Transcription factors: structural families and principles of DNA recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

On the nature of antibody combining sites: Unusual structural features that may confer on these sites an enhanced capacity for binding ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Reaction of systemic lupus erythematosus antinative DNA antibodies with native DNA fragments from 20 to 1,200 base pairs

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Artifacts and limitations of enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Anti-DNA antibodies bind to DNase I.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

The spectrum of ciclosporin nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Genetic and structural evidence for antigen selection of anti-DNA antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

16 Analysis of equilibrium and kinetic measurements to determine thermodynamic origins of stability and specificity and mechanism of formation of site-specific complexes between proteins and helical DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

The use of methotrexate in steroid-resistant systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Delayed androgen treatment prolongs survival in murine lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Role of Fas/FasL interaction in physiology and pathology: the good and the bad.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Long-term thromboxane-synthase inhibition prolongs survival in murine lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Modulation of the immunoglobulin dysregulation in GvH- and SLE-like diseases by the murine IL-4 receptor (IL-4-R)

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Methotrexate treatment in murine experimental systemic lupus erythematosus (SLE); clinical benefits associated with cytokine manipulation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Idiotypes in Systemic Lupus Erythematosus (Part 1 of 2)

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Idiotypic cross-reactions of monoclonal human lupus autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

The use of polyethylene glycol precipitation to detect low-avidity anti-DNA antibodies in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Thromboxane receptor blockade reduces renal injury in murine lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Evidence for sequence-specific recognition of DNA by anti-single-stranded DNA autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

A recognition site on synthetic helical oligonucleotides for monoclonal anti-native DNA autoantibody

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

The antigenic determinants of denatured DNA reactive with lupus erythematosus serum

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Ligand recognition by anti-DNA autoantibodies. Affinity, specificity, and mode of binding

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Ligand recognition by murine anti-DNA autoantibodies. II. Genetic analysis and pathogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Thermodynamic analysis of monoclonal antibody binding to duplex DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Cross-reactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Anti-DNA antibodies can bind to the glomerulus via two distinct mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Elucidation of anti-ssDNA autoantibody BV 04-01 binding interactions with homooligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

A comparative immunologic analysis of several murine strains with autoimmune manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor [see commetns].

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Effect of low-dose cyclosporin A on systemic lupus erythematosus disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Structural Features of Nephritogenic Lupus Autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Specific cellular stimulation in the primary immune response: a quantized model

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

Mechanism of action of hydroxychloroquine as an antirheumatic drug

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900022-4

7 January 2021

10.1016/S0163-7258(99)00022-4

Identifiers

DOI

1 reference

29 July 2017

1 reference